A paradigm shift may be necessary to increase the adoption of Electronic Clinical Outcome Assessments (eCOA) in clinical research. Explore six pivotal areas where eCOA standards can be improved.

A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.

Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.

Discover how Medable and industry leaders are accelerating clinical research and transforming patient care in the era of digital innovation.

Effortlessly conduct multi-center clinical trials worldwide for drug development with Castor’s EDC and CDMS platforms, including eCOA, ePRO, EHR eSource, eConsent, and IRT modules.

Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.

This study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.

Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.